Company profile
Rhaeos
🩹wearable sensors // FDA breakthrough devices //MedTech Innovator Winner (#1 out of >1000) // NSF & NIH funded
- Industry
- Medical Equipment Manufacturing
- Employees
- 19
- Headquarters
- Evanston, Illinois
- Founded
- 2018
- LinkedIn followers
- 3,772
- Office locations
- 2
Rhaeos company summary
Rhaeos is a company in the Medical Equipment Manufacturing industry, headquartered in Evanston, Illinois, founded in 2018. On LinkedIn the company has around 19 employees and 3,772 followers. The company lists 2 office locations. Its listed specialties include neurosurgery, hydrocephalus, bioengineering, materials science, neurology.
What technology does Rhaeos use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Rhaeos
Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now with FlowSense. FlowSense, is a proprietary wireless, wearable, and noninvasive sensor that can be mounted on skin overlying the shunt to detect the presence and magnitude of CSF. Its miniaturized, thin construction is similar in size to a bandage, and it is composed primarily of soft, silicone rubber with no hard edges. Data is wirelessly transmitted to a custom designed mobile app. Rhaeos received FDA breakthrough designation for FlowSense, is NIH and NSF funded (>$7.5M), published clinical data in Science and Nature family journals, and is on track for initial market entry in 2024. To date, the company has brought in >$19M in dilutive and non-dilutive financing. Follow on products for other chronic conditions are currently in development.
Specialties
Where is Rhaeos located?
Rhaeos lists 2 office locations.
Compare companies similar to Rhaeos
More companies in Medical Equipment Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Rhaeos rhaeos.com | Medical Equipment Manufacturing | 19 | 2018 | Evanston, Illinois |
 Boston Scientific bostonscientific.com | Medical Equipment Manufacturing | 54,970 | - | Marlborough, MA |
 BD bd.com | Medical Equipment Manufacturing | 46,224 | - | Franklin Lakes, New Jersey |
 Baxter International Inc. baxter.com | Medical Equipment Manufacturing | 39,218 | - | Deerfield, Illinois |
 Alcon alcon.com | Medical Equipment Manufacturing | 27,667 | - | Geneva, Switzerland |
 Smith+Nephew smith-nephew.com | Medical Equipment Manufacturing | 19,271 | - | Watford, Hertfordshire, GB |
 Zimmer Biomet EMEA zimmerbiomet.com | Medical Equipment Manufacturing | 19,125 | - | Warsaw, Indiana |
 Olympus Corporation olympus-global.com | Medical Equipment Manufacturing | 13,703 | 1919 | Shinjuku-ku, Tokyo |
 Intuitive intuitive.com | Medical Equipment Manufacturing | 13,091 | 1995 | California, 94086 |
 Medline Australia medline.com | Medical Equipment Manufacturing | 18,899 | - | Northfield, IL |
 Edwards Lifesciences edwards.com | Medical Equipment Manufacturing | 14,197 | 1958 | Irvine, CA |
Frequently asked questions about Rhaeos
What does Rhaeos do?
Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now with FlowSense. FlowSense, is a proprietary wireless, wearable, and noninvasive sensor that can be mounted on skin overlying the shunt to detect the presence and magnitude of CSF. Its miniaturized, thin construction is similar in size to a bandage, and it is composed primarily of soft, silicone rubber with no hard edges. Data is wirelessly transmitted to a custom designed mobile app. Rhaeos received FDA breakthrough designation for FlowSense, is NIH and NSF funded (>$7.5M), published clinical data in Science and Nature family journals, and is on track for initial market entry in 2024. To date, the company has brought in >$19M in dilutive and non-dilutive financing. Follow on products for other chronic conditions are currently in development.
How many employees does Rhaeos have?
Rhaeos has around 19 employees on LinkedIn.
Where is Rhaeos headquartered?
Rhaeos is headquartered in Evanston, Illinois.
Where does Rhaeos have offices?
Rhaeos lists 2 office locations, including Evanston, Illinois, US; Chicago, IL, US.
When was Rhaeos founded?
Rhaeos was founded in 2018.
Build a lead list from companies like Rhaeos
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.